We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Grocery Outlet
GO
$891M
| $49.4M | 0.11% |
1,484,022
+506,154
| +52% | +$20.6M |
|
202
Performance Food Group
PFGC
$17.5B
| $49.4M | 0.11% |
1,149,777
+123,158
| +12% | +$6.09M |
|
|
AAC
203
DELISTED
Ares Acquisition Corporation
AAC
| $49.4M | 0.11% |
4,970,350
| – | – |
|
204
Amphenol
APH
$188B
| $49.2M | 0.11% |
1,470,556
+899,032
| +157% | +$32.7M |
|
205
M&T Bank
MTB
$36.2B
| $49M | 0.11% |
+278,082
| New | +$49.2M |
|
206
CALL
iShares China Large-Cap ETF
FXI
$4.31B
| $49M | 0.11% |
1,895,300
+1,370,100
| +261% | +$41M |
|
207
CALL
NVIDIA
NVDA
$5.01T
| $48.6M | 0.11% |
4,001,000
+1,832,000
| +84% | +$29M |
|
208
Yum China
YUMC
$14.9B
| $48.5M | 0.11% |
1,016,042
+38,862
| +4% | +$1.87M |
|
209
Nucor
NUE
$56.4B
| $47.2M | 0.1% |
441,468
+310,126
| +236% | +$38.9M |
|
210
D.R. Horton
DHI
$41B
| $47.2M | 0.1% |
700,881
+421,530
| +151% | +$31M |
|
211
Deutsche Bank
DB
$66.3B
| $47.2M | 0.1% |
6,299,298
-4,719,434
| -43% | -$40.1M |
|
212
Hilton Worldwide
HLT
$74B
| $46.9M | 0.1% |
389,156
+167,042
| +75% | +$21.1M |
|
213
Bilibili
BILI
$7.18B
| $46.8M | 0.1% |
3,051,860
-784,534
| -20% | -$17.9M |
|
214
Axalta
AXTA
$7.01B
| $46.6M | 0.1% |
2,211,780
-2,587,384
| -54% | -$63.6M |
|
215
J.M. Smucker
SJM
$12.6B
| $46.4M | 0.1% |
337,308
-140,970
| -29% | -$19.2M |
|
216
Cytokinetics
CYTK
$11B
| $46.3M | 0.1% |
955,886
-397,251
| -29% | -$19.1M |
|
217
Nike
NKE
$61.9B
| $45.9M | 0.1% |
552,304
+539,903
| +4,354% | +$58.1M |
|
|
218
PUT
NVIDIA
NVDA
$5.01T
| $45.6M | 0.1% |
3,759,000
+3,177,000
| +546% | +$50.2M |
|
219
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $45.5M | 0.1% |
573,700
+544,700
| +1,878% | +$45.9M |
|
220
Gen Digital
GEN
$15.6B
| $45.5M | 0.1% |
2,258,752
-7,077,432
| -76% | -$164M |
|
221
Corebridge Financial
CRBG
$14.1B
| $45.2M | 0.1% |
+2,293,651
| New | +$47.2M |
|
222
Rio Tinto
RIO
$148B
| $45.1M | 0.1% |
818,682
+529,206
| +183% | +$30.5M |
|
223
APA Corp
APA
$12.8B
| $44.8M | 0.1% |
1,310,394
+1,243,667
| +1,864% | +$44.5M |
|
224
Okta
OKTA
$24.1B
| $44.6M | 0.1% |
783,715
+411,975
| +111% | +$35.4M |
|
225
Synchrony
SYF
$23.7B
| $44.5M | 0.1% |
1,579,673
-549,473
| -26% | -$17.7M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.